HomeInsightsStock Comparison

Neuland Laboratories Ltd vs Veerhealth Care Ltd Stock Comparison

Neuland Laboratories Ltd vs Veerhealth Care Ltd Stock Comparison

Last Updated on: Jun 15, 2025

Key Highlights

  • The Latest Trading Price of Neuland Laboratories Ltd is ₹ 13190 as of 13 Jun 15:30.
  • The P/E Ratio of Neuland Laboratories Ltd changed from 22.5 on March 2020 to 27 on March 2024 . This represents a CAGR of 3.71% over 5 yearsThe P/E Ratio of Veerhealth Care Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Neuland Laboratories Ltd changed from ₹ 363.66 crore on March 2020 to ₹ 8058 crore on March 2024 . This represents a CAGR of 85.83% over 5 yearsThe Market Cap of Veerhealth Care Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Neuland Laboratories Ltd for the Mar '25 is ₹ 335.82 crore as compare to the Dec '24 revenue of ₹ 457.72 crore. This represent the decline of -26.63% The revenue of Veerhealth Care Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Neuland Laboratories Ltd for the Mar '25 is ₹ 58.54 crore as compare to the Dec '24 ebitda of ₹ 146.28 crore. This represent the decline of -59.98% The ebitda of Veerhealth Care Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Neuland Laboratories Ltd changed from ₹ 61.88 crore to ₹ 27.81 crore over 8 quarters. This represents a CAGR of -32.96% The net profit of Veerhealth Care Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Neuland Laboratories Ltd changed from 16.25 % on March 2020 to 6.03 % on March 2024 . This represents a CAGR of -17.99% over 5 yearsThe Dividend Payout of Veerhealth Care Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Neuland Laboratories Ltd

  • Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
  • The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin.
  • Neuland Drugs & Pharmaceuticals Pvt.
  • Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
  • NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.

About Veerhealth Care Ltd

  • Veerhealth Care Limited was originally incorporated on 10 July, 1992 as Niyati Leasing Limited to start business in Investment and Finance.
  • The main objects of the Company in 1998 got changed and accordingly the name was changed from Niyati Leasing Limited to Niyati Industries Limited and from Niyati Industries Limited to Veerhealth Care Limited in May, 2013. Initially in 2010, the Company was engaged into dealing and trading of shares, securities, debentures, and other investments.
  • It wanted to start business in the field of infrastructure.
  • Later on, the Company through the Main Objects, diversify the business activities to Pharma sector in 2013.
  • Apart from Tablet, Syrup, Ointment, Powder, it also started manufacturing in the Oil, Shampoo, Ointment and Toothpaste Division in year 2015-16.

Neuland Laboratories Ltd News Hub

News

Neuland Laboratories to hold AGM

Neuland Laboratories announced that the 41th Annual General Meeting(AGM) of the company wi...

Read more

17 May 2025 12:57

News

Neuland Labs drops after Q4 PAT slumps 59% YoY to Rs 28 cr

On quarter on quarter (QoQ) basis, the company's net profit declined 72.63% while revenue ...

Read more

16 May 2025 14:51

News

Board of Neuland Laboratories recommends Final Dividend

Neuland Laboratories announced that the Board of Directors of the Company at its meeting h...

Read more

15 May 2025 16:52

News

Neuland Laboratories to announce Quarterly Result

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 15 Ma...

Read more

25 Apr 2025 10:43

News

Neuland Laboratories Ltd Spurts 2.02%

Neuland Laboratories Ltd gained 2.02% today to trade at Rs 13000. The BSE Healthcare index...

Read more

17 Apr 2025 09:30

News

Neuland Laboratories appoints Head - Manufacturing

Neuland Laboratories announced that Parag Deshmukh has been appointed as Head - Manufactur...

Read more

10 Mar 2025 15:29

Veerhealth Care Ltd News Hub

News

Veerhealth Care did not recommend dividend

The Board of Star Delta Transformers at the meeting held on 30 May 2025, has decided not d...

Read more

30 May 2025 12:01

News

Veerhealth Care to discuss results

Veerhealth Care will hold a meeting of the Board of Directors of the Company on 30 May 202...

Read more

22 May 2025 14:53

News

Veerhealth Care to conduct board meeting

Veerhealth Care will hold a meeting of the Board of Directors of the Company on 12 Februar...

Read more

05 Feb 2025 12:51

News

Veerhealth Care to conduct board meeting

Veerhealth Care will hold a meeting of the Board of Directors of the Company on 14 Novembe...

Read more

08 Nov 2024 10:43

News

Veerhealth Care to convene AGM

Veerhealth Care announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

30 Aug 2024 16:47

News

Veerhealth Care to declare Quarterly Result

Veerhealth Care will hold a meeting of the Board of Directors of the Company on 14 August ...

Read more

09 Aug 2024 14:40

SWOT Analysis Of Veerhealth Care Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Neuland Laboratories Ltd

Strength

5

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Veerhealth Care Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Neuland Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Neuland Laboratories Ltd and Veerhealth Care Ltd

Which company has a larger market capitalization, Neuland Laboratories Ltd or Veerhealth Care Ltd?

Market cap of Neuland Laboratories Ltd is 16,923 Cr while Market cap of Veerhealth Care Ltd is 35 Cr

What are the key factors driving the stock performance of Neuland Laboratories Ltd and Veerhealth Care Ltd?

The stock performance of Neuland Laboratories Ltd and Veerhealth Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Neuland Laboratories Ltd and Veerhealth Care Ltd?

As of June 15, 2025, the Neuland Laboratories Ltd stock price is INR ₹13190.3. On the other hand, Veerhealth Care Ltd stock price is INR ₹17.86.

How do dividend payouts of Neuland Laboratories Ltd and Veerhealth Care Ltd compare?

To compare the dividend payouts of Neuland Laboratories Ltd and Veerhealth Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions